Kenvue stock drops 4% post-Morgan Stanley conference
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Kenvue Inc (KVUE)Kenvue Inc stock price live, this page displays NYSE KVUE stock exchange data. View the KVUE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Kenvue Inc real time stock price chart below.
What Is the Kenvue Inc Stock Price Today?
The Kenvue Inc stock price today is 22.84.
What Is the Stock Symbol for Kenvue Inc?
The stock symbol for Kenvue Inc is "KVUE."
What Stock Exchange Does Kenvue Inc Trade On?
Kenvue Inc is listed and trades on the NYSE stock exchange.
Is Kenvue Inc a Good Stock to Buy?
Determining whether Kenvue Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KVUE quote. (ISIN: US49177J1025)
What Is the Kenvue Inc Stock Price Today?
The Kenvue Inc stock price today is 22.84.
What Is the Stock Symbol for Kenvue Inc?
The stock symbol for Kenvue Inc is "KVUE."
What Stock Exchange Does Kenvue Inc Trade On?
Kenvue Inc is listed and trades on the NYSE stock exchange.
Is Kenvue Inc a Good Stock to Buy?
Determining whether Kenvue Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KVUE quote. (ISIN: US49177J1025)
22.84
-0.29(-1.25%)
Closed
After Hours
23.08+0.24(+1.05%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
22.82
23.35
52 wk Range
17.67
24.46
KVUE Scorecard
Full Analysis
Impressive gross profit margins
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
22.8223.35
52 wk Range
17.6724.46
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
Unlock(3.59%)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
Unlock(3.59%)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockKVUE Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Price Target
24.68
Upside
+8.06%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
5 analysts have revised their earnings downwards for the upcoming period
Kenvue Inc Company Profile
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women’s health, wound, and other care products under the Listerine, Johnson’s, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.
Kenvue Inc SWOT Analysis
Post-Spinoff Dynamics | Explore Kenvue's journey as an independent entity, navigating challenges and opportunities in the competitive consumer health market after its separation from Johnson & Johnson. |
Financial Resilience | Discover Kenvue's solid organic sales growth and impressive gross margin expansion, particularly in Essential Health and Self Care divisions, supporting reinvestment plans. |
Segment Performance | Delve into the contrasting performances of Kenvue's segments, with Essential Health and Self Care driving growth while Skin Health & Beauty faces challenges and scrutiny. |
Future Trajectory | Analyst price targets range from $20 to $25, reflecting cautious optimism about Kenvue's potential for continued momentum and ability to overcome inventory and market challenges. |
KVUE Full Pro Research
Institutional-Grade Stock Analysis
Understand how KVUE earns money
Financial health at a glance
Bearish and bullish outlooks
Latest expert insights
Actionable Pro Tips, and many more...
Gain access to 1400+ in-depth research reports on the most popular US stocks
Kenvue Inc Earnings Call Summary for Q3/2024
- Organic growth at 1.5% YoY, driven by Essential Health; adjusted gross profit margin up 410 bps to 61.6%
- Plans to increase brand investments by up to $100M; expects to meet 2024 sales and EPS outlook ranges
- Announced first dividend increase; anticipates normal cold/flu season and positive shift in sun care consumption
- Forecasts full-year adjusted operating margin of 21-22%; confident in long-term value creation strategy
- Volume declines in Self Care and Skin Health; gross margin projected to decrease from Q2 to Q4
Last Updated: 08/08/2024, 12:52 am
Read Full TranscriptCompare KVUE to Peers and Sector
Metrics to compare | KVUE | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipKVUEPeersSector | |
|---|---|---|---|---|
P/E Ratio | 41.2x | 37.2x | 11.4x | |
PEG Ratio | −1.01 | −2.21 | 0.03 | |
Price/Book | 4.1x | 3.3x | 1.5x | |
Price / LTM Sales | 2.8x | 2.3x | 0.9x | |
Upside (Analyst Target) | 8.2% | −14.8% | 17.6% | |
Fair Value Upside | Unlock | 1.6% | 8.0% | Unlock |
Analysts' Recommendations
6 Buy
10 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 24.68
(+8.07% Upside)
Dividends
Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.556
Dividend Yield
3.55%
Industry Median 2.21%
Annualised payout
0.8200
Paid quarterly
5-Years Growth
-
Growth Streak
People Also Watch
FAQ
What Is the Kenvue (KVUE) Stock Price Today?
The Kenvue stock price today is 22.84
What Stock Exchange Does Kenvue Trade On?
Kenvue is listed and trades on the NYSE stock exchange.
What Is the Stock Symbol for Kenvue?
The stock symbol for Kenvue is "KVUE."
Does Kenvue Pay Dividends? What’s The Current Dividend Yield?
The Kenvue dividend yield is 3.59%.
What Is the Kenvue Market Cap?
As of today, Kenvue market cap is 43.79B.
What is Kenvue Earnings Per Share?
The Kenvue EPS is 0.556.
What Is the Next Kenvue Earnings Date?
Kenvue will release its next earnings report on 05 Feb 2025.
From a Technical Analysis Perspective, Is KVUE a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.